RECENT COMMENTS

Constantinos Zambirinis (Thyroid cancer management): As you mentioned above, differentiated thyroid cancer is followed after treatment with the thyroglob [...]   »Read more

Dr Lobna Sedky (Serigne Magueye Gueye): Within Africa,the scope of cancer differs even between various geographic regions. Being an oncologi [...]   »Read more

DR PUSHKAL DWIVEDI (World Cancer Declaration): I FULLY AGREE!   »Read more

Dr Olayinka O Adegbehingbe (World Cancer Declaration): Dear Prof Franco Cavalli, The World Cancer Declaration is great and impacts in developing countries [...]   »Read more

Tung Dinh Nguyen (World Cancer Declaration): Dear Dr F Cavalli, I have had a lot of chance to see Dr F. Cacalli In Hue, Vietnam. The World Ca [...]   »Read more

Drug Watch

Issue 32
Gotta get that rhythm: circadian timing systems and cancer
Issue 31
Beyond trench warfare: American and European researchers in search of a winning strategy
Issue 30
Health rationing in Europe: can cancer get a fair hearing?
Issue 28
Oncology’s successes must not fail the heart
Issue 27
When is it OK to randomise cancer patients to placebo?
Issue 26
Stopping trials prematurely: sorting the right decisions from the wrong
Issue 25
Personalised medicine: the dream and the reality
Issue 24
How Europe is taking on the big biobank challenge
Issue 21
Dying for a lack of compassion?
Issue 20
Healthcare rationing: the moral dilemma
Issue 19
HPV vaccine promises much but screening remains vital  
Issue 18
Bringing personalised cancer treatments to the people
Issue 17
No-name heroes can save Europe billions
Issue 16
Fast and effective?  
Issue 13
RNA-bound: the future of antisense drugs
Issue 12
PHARE: shining a light for academic reasearch in Europe
Issue 5
Brainwaves in drug delivery
Issue 4
Let’s talk Chinese milk vetch
Issue 3
Europe set to act over paediatric drugs  
Issue 1
Cancer vaccines – hope or hype  

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR109 - The challenge of ovarian cancer in relapse

GR110 - Permanent implant prostate brachytherapy: The state-of-the-art

GR111 - Breast cancer chemoprevention: What is new?

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, GlaxoSmithKline, Merck and Novartis.